Nima Ghamsari

All filings by Nima Ghamsari on record concern Blend Labs, Inc., in the capacity of senior executive. In total, 50 filings cover trades dated from 20 July 2021 to 12 October 2026.

No open-market purchase appears, only 10 sales worth €1.6M. Outside the open market, there are 2 share grants and 16 option exercises. In 2026 alone, the filings show no purchases and 5 sales.

On 14 October 2026 came the latest disclosure, an open-market sale for €22k in Blend Labs, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.